Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
USD 630.00
2 Weeks
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | CT, ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
| Applications | Bl, FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |